Is CLSD or QYLD a better dividend investment in 2026?

CLSD currently yields 487.80% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CLSD offers higher current income.

What is the dividend yield difference between CLSD and QYLD?

CLSD has a forward dividend yield of 487.80% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 475.88 percentage points.

Home › Compare › CLSD vs QYLD

CLSD vs QYLD: Dividend Comparison 2026

CLSD yields 487.80% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSD wins by $50753.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSD

● Live price

487.80%

Share price

$0.41

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$50753.89M

Annual income

$36,168,404,531.85

Full CLSD calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CLSD vs QYLD

📍 CLSD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSD	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSD + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSD pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSD

Annual income on $10K today (after 15% tax)

$41,463.41/yr

After 10yr DRIP, annual income (after tax)

$30,743,143,852.07/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CLSD beats the other by $30,743,139,041.66/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSD + QYLD for your $10,000?

CLSD: 50%QYLD: 50%

100% QYLD50/50100% CLSD

Portfolio after 10yr

$25376.96M

Annual income

$18,084,205,095.59/yr

Blended yield

71.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLSD right now

CLSD

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-48.3

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSD buys

QYLD buys

Politician	Chamber	Ticker	Type	Amount	Date
Tim Moore	🏢 House	$QYLD	▼ Sell	$15,001 - $50,000	2025-05-02
Tim Moore	🏢 House	$QYLD	▲ Buy	$15,001 - $50,000	2025-04-07
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2022-11-14
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2020-10-29

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSDQYLD

Forward yield	487.80% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$50753.89M ✓	$25.4K
Annual income after 10y	$36,168,404,531.85 ✓	$5,659.31
Total dividends collected	$49478.61M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CLSD vs QYLD ($10,000, DRIP)

Year	CLSD Portfolio	CLSD Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$59,480	$48,780.49	$10,352	$1,192.36	+$49.1K → CLSD
2	$334,811	$271,167.03	$10,830	$1,347.57	+$324.0K → CLSD
3	$1,784,770	$1,426,522.08	$11,460	$1,539.07	+$1.77M → CLSD
4	$9,016,553	$7,106,848.63	$12,275	$1,777.84	+$9.00M → CLSD
5	$43,202,271	$33,554,559.81	$13,323	$2,078.95	+$43.19M → CLSD
6	$196,483,123	$150,256,693.49	$14,667	$2,463.34	+$196.47M → CLSD
7	$848,895,486	$638,658,543.63	$16,396	$2,960.57	+$848.88M → CLSD
8	$3,487,095,949	$2,578,777,778.75	$18,631	$3,612.97	+$3487.08M → CLSD
9	$13,631,297,985	$9,900,105,319.66	$21,548	$4,482.15	+$13631.28M → CLSD
10	$50,753,893,375	$36,168,404,531.85	$25,398	$5,659.31	+$50753.87M → CLSD

CLSD vs QYLD: Complete Analysis 2026

CLSD — Stock

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Full CLSD Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CLSD vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSD vs SCHD CLSD vs JEPI CLSD vs O CLSD vs KO CLSD vs MAIN CLSD vs XYLD CLSD vs JEPQ CLSD vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.